5 Reasons LD May Outperform EVD in aSAH: Is Lumbar Drainage the Superior Strategy?
International Journal of Stroke (IJS), official journal of World Stroke Organization, shared a newly piblished study on X:
”New systematic review and meta analysis compares outcomes of external ventricular drainage and lumbar drainage in aSAH. When directly compared, LD was favored to EVD for early functional independence and survival”
Read the full article here.
In patients with aneurysmal subarachnoid hemorrhage (aSAH), cerebrospinal fluid diversion via lumbar drainage (LD) or external ventricular drainage (EVD) plays a critical role in managing complications.
In the recently published comprehensive meta-analysis ‘‘Outcomes of External Ventricular Drainage, and Lumbar Drainage in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review, and Meta-Analysis” by Basel Musmar, Pascal Jabbour et al. in the IJS, a comparative overview of LD and EVD approaches in aSAH is discussed.
- LD was associated with lower risks of vasospasm, ischemic complications, severe disability, and mortality without an increased risk of rebleeding.
- EVD effectively reduced ischemic events but carried a higher infection risk.
Direct comparisons suggest LD may offer advantages in early functional recovery and survival, though clinical context and patient severity remain key considerations.
Further research is warranted to guide optimal intervention strategies!

All the latest scientific advancements in the field of thrombosis and bleeding featured in Hemostasis Today.
-
Sep 3, 2026, 17:48Isabel Sá: Starting a New Chapter as a Clinical Scientist in Molecular Genetics and Haematology
-
Sep 3, 2026, 17:40Chiwoo Oh: AS01B Adjuvant and Long-Term Immune Reprogramming After Shingrix Vaccination
-
Sep 3, 2026, 17:35Key Developments in Transfusion Medicine and Biotherapies in 2025 – AABB
-
Sep 3, 2026, 17:24N. Mariana S. Vasquez: JAK2 Mutations The High-Yield Map of Myeloproliferative Neoplasms
-
Sep 3, 2026, 17:08Khusi Dhara: Why Women Need to Pay Attention to Iron
-
Sep 3, 2026, 16:54Ralf Ludwig։ Testing Human-Targeted Therapies in a Human Immune System
-
Sep 3, 2026, 16:35Mohsen Salimi: Non-Contrast Chest CT as a Biomarker for Mild-to-Moderate Anemia
-
Sep 3, 2026, 16:10Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia
-
Sep 3, 2026, 15:42Manuel De Jesus: Innovating Anemia Monitoring Through Biomedical Engineering and Digital Technology